StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences viread (tenofovir disoproxil fumarate — legacy breakout) — Rest of World sales ($M) ($M)

Form 10-Q / 10-K Disaggregated Revenue Note & Form 8-K Product Sales Summary

QuarterlyAnnual
Latest, Q4 2023
12
Period ended Dec 31, 2023
Change on a year earlier
-14.3%
14 in Q4 2022
History
29 quarters
Since Q4 2016
Sources
21
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedViread (tenofovir disoproxil fumarate — legacy breakout) — Rest of World sales ($M) ($M)Year on yearSource
Q4 2023Dec 31, 202312-14.3%Form 10-K (filed 2024-02-23) ↗
Q3 2023Sep 30, 202312-20.0%Form 10-Q (filed 2023-11-07) ↗
Q2 2023Jun 30, 202314-6.7%Form 10-Q (filed 2023-08-04) ↗
Q1 2023Mar 31, 202314-17.6%Form 10-Q (filed 2023-05-03) ↗
Q4 2022Dec 31, 202214-17.6%Form 10-K (filed 2024-02-23) ↗
Q3 2022Sep 30, 202215-16.7%Form 10-Q (filed 2023-11-07) ↗
Q2 2022Jun 30, 202215-11.8%Form 10-Q (filed 2023-08-04) ↗
Q1 2022Mar 31, 202217-15.0%Form 10-Q (filed 2023-05-03) ↗
Q4 2021Dec 31, 202117-54.1%Form 10-K (filed 2024-02-23) ↗
Q3 2021Sep 30, 202118-14.3%Form 10-Q (filed 2022-11-02) ↗
Q2 2021Jun 30, 202117-68.5%Form 10-Q (filed 2022-08-08) ↗
Q1 2021Mar 31, 202120-20.0%Form 10-Q (filed 2022-05-04) ↗
Q4 2020Dec 31, 202037+60.9%Form 10-K (filed 2023-02-22) ↗
Q3 2020Sep 30, 202021-40.0%Form 10-Q (filed 2021-11-03) ↗
Q2 2020Jun 30, 202054+42.1%Form 10-Q (filed 2021-08-05) ↗
Q1 2020Mar 31, 202025-45.7%Form 10-Q (filed 2020-05-06) ↗

Cite this data

StockData. (2026). Gilead Sciences Viread (tenofovir disoproxil fumarate — legacy breakout) — Rest of World sales ($M) ($M), quarterly Q4 2016–Q4 2023 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/liver_viread_row

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.